Cargando…
Acellular ex vivo lung perfusate silences pro-inflammatory signaling in human lung endothelial and epithelial cells
BACKGROUND: Ischemia–reperfusion injury is a key complication following lung transplantation. The clinical application of ex vivo lung perfusion (EVLP) to assess donor lung function has significantly increased the utilization of “marginal” donor lungs with good clinical outcomes. The potential of EV...
Autores principales: | Jeon, Jamie E., Huang, Lei, Zhu, Zhiyuan, Wong, Aaron, Keshavjee, Shaf, Liu, Mingyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580637/ https://www.ncbi.nlm.nih.gov/pubmed/37845763 http://dx.doi.org/10.1186/s12967-023-04601-w |
Ejemplares similares
-
Ex vivo lung perfusion
por: Watanabe, Tatsuaki, et al.
Publicado: (2021) -
De Novo Design and Development of a Nutrient-Rich Perfusate for Ex Vivo Lung Perfusion with Cell Culture Models
por: Huang, Lei, et al.
Publicado: (2023) -
Increased Arginase Expression and Decreased Nitric Oxide in Pig Donor Lungs after Normothermic Ex Vivo Lung Perfusion
por: Tavasoli, Farshad, et al.
Publicado: (2020) -
Evaluating the Impact of Ex Vivo Lung Perfusion on Organ Transplantation: A Retrospective Cohort Study
por: Peel, John K., et al.
Publicado: (2023) -
Incidence of post-transplant cytomegalovirus viremia in patients receiving lungs after ex vivo lung perfusion
por: Ribeiro, Rafaela V.P., et al.
Publicado: (2023)